Aplasia
Conditions
Brief summary
It is currently not allowed for patients with prolonged aplasia, following intensive chemotherapy, to brush teeth due to the risk of damaging the oral mucosa with risk of haemorrhage and infectious entrance door. Mouthwash is currently prescribed to prevent these complications. Many patients, however, ask to brush their teeth for greater comfort and a feeling of well-being. Some haematology services allow tooth brushing while others prohibit tooth brushing without study. Investigators wanted to conduct a study to assess the feasibility, the safety of tooth brushing for aplastic patient comfort, hemopathy and/or chemotherapies causing mucous membrane alteration that increases infectious risk and the risk of gingivorragia.
Interventions
DEVICEToothbrush
Brushing teeth three times a day (extra-soft toothbrush) with a 1.4% baking mouthwash solution.
DRUGMouthwashes
Mouthwashes three times a day with a 1.4% baking mouthwash solution.
Sponsors
University Hospital, Angers
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Hospitalized Patients in protected area of the Blood Disease Service with predictable prolonged aplasia and risk of mucite * Acute myeloblastic leukemia undergoing induction or consolidation treatment * Acute lymphoblastic leukemia under induction treatment * Patients affiliated or beneficiaries of a social security * Written inform consent
Exclusion criteria
* Patients with removable complete dentures * Constitutional disorder of coagulation * Hematopoietic stem cell allogreffe * Therapeutic intensification with autograft of haematopoietic stem cells * Patient unable to provide oral care alone (brushing teeth or mouthwash) * Already included in the study * Pregnant women, lactating mothers * Persons deprived of liberty by an administrative or judicial decision * Persons undergoing psychiatric care under duress * Adults who are subject to a legal or non-state protection measure to express their consent
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Highest score obtained at the OAG (Oral Assessment Guide) scale during the observation period | 1 month | Assess the effect of the teeth brushing versus mouth bath strategy on the oral condition of patients hospitalized in the protected area of the Blood Disease Service with predictable prolonged aplasia and risk of mucite |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Number of days with morphinic treatment | 1 month | Estimate the effect of the strategy in terms of pain |
| Percentage of patients receiving parenteral nutrition during hospitalization | 1 month | Estimate the effect of the strategy in terms of patient's tolerance to oral care |
| Number of days with parenteral nutrition | 1 month | Estimate the effect of the strategy in terms of patient's tolerance to oral care |
| Number of septicemia | 1 month | Estimate the effect of the strategy in terms of Infectious risks |
| Incidence of intra-oral hemorrhage | 1 month | Estimate the effect of the strategy in terms of Hemorrhagic risk |
| Percentage of patients receiving morphinics during hospitalization | 1 month | Estimate the effect of the strategy in terms of pain |
| Number of days with fever | 1 month | Estimate the effect of the strategy in terms of Infectious risks |
| Incidence of bacterial infections during hospitalization | 1 month | Estimate the effect of the strategy in terms of Infectious risks |
| Incidence of fungal infections during hospitalization | 1 month | Estimate the effect of the strategy in terms of appearance of mucite |
| Percentage of patients who had to discontinue treatment on medical advice | 1 month | Estimate the effect of the strategy in terms of patient's tolerance to oral care |
| Number of days with intra-oral hemorrhage | 1 month | Estimate the effect of the strategy in terms of Hemorrhagic risk |
Countries
France
Outcome results
None listed